HomeOncology
Oncology
Improving survival rates for patients with colorectal cancer
Patients with colorectal cancer tumours on the right side may have poorer five-year survival rates than those whose tumours are located on the left...
Blood test predicts specific prostate cancer treatment response
An international collaborative study between Lawson Health Research Institute, Memorial Sloan Kettering Cancer Centre, the Royal Marsden Hospital and Epic Sciences is one of...
Testosterone effective in combating cachexia in cancer patients
In patients with advanced cancer undergoing early standard of care therapy, adjunct testosterone improved lean body mass and was also associated with increased quality...
Antibody blood test to detect melanoma in its early stages
Australian researchers are claiming a breakthrough with a blood test for early stage melanoma. In a trial involving 105 patients with melanoma and 104 healthy...
Mammogram screening study supports the exclusion of low-risk women
A UK modelling study concluded that excluding the screening of low risk women would improve the quality of life gained, reduce over-diagnosis and save...
Ultrasound may be superior for treatment of prostate cancer
Using high energy ultrasound beams to destroy prostate cancer tumours may be as effective as surgery or radiotherapy, but with fewer side effects, a...
Fivefold improvement in glioblastoma survival with polio-virus therapy
A genetically modified poliovirus therapy developed at Duke Cancer Institute shows significantly improved long-term survival for patients with recurrent glioblastoma, with a three-year survival...
Environment predicts men's testosterone levels
Men's testosterone levels are largely determined by their environment during childhood found a UK study, challenging the theory that testosterone levels are controlled by...
Vitamin D linked to reduced breast cancer risk
Researchers at University of California – San Diego School of Medicine suggest higher levels of vitamin D are associated with decreasing risk of breast...
Higher body fat link to lower breast cancer risk in pre-menopausal women
While obesity has been shown to increase breast cancer risk in post-menopausal women, a large-scale study co-led by a University of North Carolina Lineberger...
Personalised glioblastoma vaccine may increase long-term survival
An international Phase III study led by researchers at the University of California – Los Angeles (UCLA) and at Northwest Biotherapeutics Inc has found...
Study on first birth cohort to receive HPV vaccine
Girls in the first birth cohort to receive the HPV vaccine showed a lower degree of dysplasia which may eventually lead to cervical cancer...
Immune checkpoint inhibitor shrinks incurable skin cancer tumours
Clinical trials show that an immune checkpoint inhibitor shrinks the tumours of nearly half of patients with incurable, advanced cutaneous squamous-cell carcinoma, an international...
Little benefit from frequent monitoring of post-Tx prostate cancer
Prostate cancer patients who were monitored more frequently after treatment did not live significantly longer than patients who were monitored once a year, according...
No benefit from chemo for 70% of those with early breast cancer — TAILORx
Findings from the ground-breaking Trial Assigning Individualised Options for Treatment (Rx) (TAILORx) trial, show no benefit from chemotherapy for 70% of women with the...
Aspirin with acid reducers helps acid reflux patients slow cancer advance
Taking aspirin with acid reducers can help patients with chronic acid reflux slow the advance of cancer of the oesophagus, the tube from the...
Novel breast cancer Tx approach led to complete regression in patient
A novel approach to immunotherapy developed by researchers at the National Cancer Institute (NCI) has led to the complete regression of breast cancer in...
Gene test could help early breast cancer patients forgo chemo
A 21-gene test performed on tumours could enable most patients with the most common type of early breast cancer to safely forgo chemotherapy, according...
Immunotherapy may halt spread of prostate cancer — UK trial
More than a third of men with an advanced form of prostate cancer were still alive and one-in-10 had not had further growth after...
Antibiotics may affect some cancer treatment outcomes
Cancer patients who took antibiotics during immunotherapy treatment lived about half as long as those who avoided the drugs, The Guardian reports a new...
Ground-breaking immunotherapy clears advanced breast cancer
A woman with advanced breast cancer which had spread around her body has been completely cleared of the disease by a ground-breaking therapy that...
Blood test may detect 10 types of cancer before tumour develops
A blood test able to detect 10 types of cancer years before a person falls ill could become available on the UK's National Health...
Non-aspirin NSAID use linked to shorter survival rates in mRCC
A University of California study has indicated that non-aspirin NSAID use was associated with shorter overall survival in patients with metastatic renal cell carcinoma...
Arterial thrombosis associated with increased incidence of cancer
Lower limb arterial thrombosis was a marker of occult cancer, especially lung cancer, and was an adverse prognostic factor for mortality in common cancers,...
Immunotherapy and chemo drug combo increases lung cancer survival rates
The immunotherapy drug pembrolizumab, when combined with chemotherapy, doubles survival in patients with non-squamous non-small cell lung cancer (NSNSCLC) lacking genetic changes in the...
Investigational drug safely and effectively treats RET-driven cancers
A phase I, first-in-human study led by The University of Texas MD Anderson Cancer Centre reveals for the first time, an investigational drug that...
Chip-based blood test for multiple myeloma may relegate bone biopsy
The diagnosis and treatment of multiple myeloma, a cancer affecting plasma cells, traditionally forces patients to suffer through a painful bone biopsy. During that...
Artificial mole as an early warning of cancer
Swiss researchers have developed and tested in mice a synthetic gene network that is implanted and serves as an early warning system against the...
One-two drug combo punch an effective treatment for lung cancers
A one-two combo punch using two currently available drugs could be an effective treatment for the majority of lung cancers, a study by scientists...
Common iron compounds may increase colon cancer risk
Two common iron compounds increase the formation of a known biomarker for cancer, according to a study of cancer cells from Chalmers University of...
High amounts of carbs may increase head and neck cancer recurrence risk
Consuming high amounts of carbohydrates and various forms of sugar during the year prior to treatment for head and neck cancer may increase patients'...
Combination Tx targets both tumour cells and tumour blood vessels
Each day, normal human cell tissues express a protein known as p53 that wages war against potential malignancies. However, between 30% and 40% of...
Higher radiation doses not improving survival in prostate cancer patients
A study shows that higher doses of radiation do not improve survival for many patients with prostate cancer, compared with the standard radiation treatment....
Promising family of silver-based anti-cancer drugs discovered
A new family of 'very promising' silver-based anti-cancer drugs has been discovered by researchers in South Africa.
The most promising silver thiocyanate phosphine complex among...
Slow-release hydrogel helps immunotherapy drug kill cancer cells
An immunotherapy drug embedded in a slow-release hydrogel invented at Rice University in collaboration with the University of Texas Health Science Centre at Houston...
High vitamin D levels may link to lower liver cancer risk
High levels of vitamin D may be linked to a lower risk of developing cancer, including liver cancer, concludes a large study of Japanese...
Active lung cancer treatment differences may be raising mortality risk
Differences in the active treatment of lung cancer across England may be cutting short the lives of hundreds of patients with the disease every...
Nuts improve colon cancer recurrence by 42%, mortality by 57%
People with stage III colon cancer who regularly eat nuts are at significantly lower risk of cancer recurrence and mortality than those who don't,...
Weighing risks and benefits in paediatric cancer trials
On average, 1 in 10 children who enrol in paediatric phase I cancer trials are improved after the trial, and 1 in 50 die...
'Obesity paradox' is a significant factor in metastatic melanoma survival
Obese patients with metastatic melanoma who are treated with targeted or immune therapies live significantly longer than those with a normal body mass index...